Assessment of treatment efficacy in HBV infection and disease

Journal of Hepatology

Volumn 44, Issue SUPPL. 1, 2006, Pages

  Zoulim, Fabien ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

Assessment; Hepatitis B; HIV; Therapy

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TENOFOVIR DISOPROXIL;

CONFERENCE PAPER; CROSS RESISTANCE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TOXICITY; LONG TERM CARE; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT FAILURE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; HEPATITIS B; HIV; HIV INFECTIONS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 30144442611     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.020     Document Type: Conference Paper

References (25)

1. A.S. Lok, and B.J. McMahon Chronic hepatitis B Hepatology 34 2001 1225 1241
2. B. Werle-Lapostolle, S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, and G. Lau Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 2004 1750 1758
3. M. Nunez, M. Puoti, N. Camino, and V. Soriano Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future Clin Infect Dis 37 2003 1678 1685
4. G.J. Dore, D.A. Cooper, C. Barrett, L.E. Goh, B. Thakrar, and M. Atkins Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-co-infected persons in a randomized, controlled study (CAESAR). The CAESAR coordinating committee J Infect Dis 180 1999 607 613
5. Y. Benhamou, C. Katlama, F. Lunel, A. Coutellier, E. Dohin, and N. Hamm Effects of Lamivudine on replication of hepatitis B virus in HIV-infected men Ann Intern Med 125 1996 705 712
6. Y. Benhamou, M. Bochet, V. Thibault, V. Di Martino, E. Caumes, and F. Bricaire Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients Hepatology 30 1999 1302 1306
7. Y. Benhamou, M. Bochet, V. Thibault, V. Calvez, M.H. Fievet, and P. Vig Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study Lancet 358 2001 718 723
8. Y. Benhamou Antiretroviral therapy and HIV/hepatitis B virus co-infection Clin Infect Dis 38 Suppl. 2 2004 S98 S103
9. Y. Benhamou, R. Tubiana, and V. Thibault Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus N Engl J Med 348 2003 177 178
10. F. Bani-Sadr, P. Palmer, C. Scieux, and J.M. Molina Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients co-infected with HIV-1 and wild-type hepatitis B virus Clin Infect Dis 39 2004 1062 1064
11. G.J. Dore, D.A. Cooper, A.L. Pozniak, E. DeJesus, L. Zhong, and M.D. Miller Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients co-infected with HIV-1 and hepatitis B virus J Infect Dis 189 2004 1185 1192
12. V. Di Martino, T. Thevenot, J.F. Colin, N. Boyer, M. Martinot, and F. Degos Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B Gastroenterology 123 2002 1812 1822
13. P. Marcellin, G.K. Lau, F. Bonino, P. Farci, S. Hadziyannis, and R. Jin Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
14. R.M. Lascar, R.J. Gilson, A.R. Lopes, A. Bertoletti, and M.K. Maini Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV co-infection J Infect Dis 188 2003 1815 1819
15. W. Lee Drug-induced hepatotoxicity N Engl J Med 333 1995 1118 1127
16. J.L. Dienstag, R.D. Goldin, E.J. Heathcote, H.W. Hann, M. Woessner, and S.L. Stephenson Histological outcome during long-term lamivudine therapy Gastroenterology 124 2003 105 117
17. P. Marcellin, T.T. Chang, S.G. Lim, M.J. Tong, W. Sievert, and M.L. Shiffman Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816
18. H. Mommeja-Marin, E. Mondou, M.R. Blum, and F. Rousseau Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature Hepatology 37 2003 1309 1319
19. S. Locarnini, A. Hatzakis, J. Heathcote, E.B. Keeffe, T.J. Liang, and D. Mutimer Management of antiviral resistance in patients with chronic hepatitis B Antivir Ther 9 2004 679 693
20. A.S. Lok, F. Zoulim, S. Locarnini, A. Mangia, G. Niro, and H. Decraemer Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay J Clin Microbiol 40 2002 3729 3734
21. S. Nafa, S. Ahmed, D. Tavan, C. Pichoud, F. Berby, and L. Stuyver Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B Hepatology 32 2000 1078 1088
22. D. Durantel, S. Carrouee-Durantel, B. Werle-Lapostolle, M.N. Brunelle, C. Pichoud, and C. Trepo A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus Hepatology 40 2004 855 864
23. H. Yang, C. Westland, S. Xiong, and W.E.T. Delaney In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector Antiviral Res 61 2004 27 36
24. C.L. Lai, J. Dienstag, E. Schiff, N.W. Leung, M. Atkins, and C. Hunt Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 36 2003 687 696
25. M.F. Yuen, E. Sablon, C.K. Hui, H.J. Yuan, H. Decraemer, and C.L. Lai Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy Hepatology 34 2001 785 791